This leads to the disassembly of the cellular MYB:CBP/P300 complex, associated with the elimination of MYB complexes from enhancers and promoters, and downregulation of MYB-dependent gene expression in AML cells. This evidence concerns the gene MYB and acute myeloid leukemia.